Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties: Infectious Disease/Hematology

68Ga-Citrate PET/CT in patents with inflammatory/infectious disease

Cristina Nanni, Vincenzo Allegri, Lorenzo Fantini, Valentina Ambrosini, Gian Carlo Montini, Paolo Castellucci, Anna Rizzello, Domenico Rubello, Cinzia Pettinato and Stefano Fanti
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 368;
Cristina Nanni
1S. Orsola Malpighi Hospital, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincenzo Allegri
1S. Orsola Malpighi Hospital, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorenzo Fantini
1S. Orsola Malpighi Hospital, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valentina Ambrosini
1S. Orsola Malpighi Hospital, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gian Carlo Montini
1S. Orsola Malpighi Hospital, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paolo Castellucci
1S. Orsola Malpighi Hospital, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Rizzello
1S. Orsola Malpighi Hospital, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Domenico Rubello
2S. Maria Della Misericordia Hospital, Rovigo, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cinzia Pettinato
1S. Orsola Malpighi Hospital, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefano Fanti
1S. Orsola Malpighi Hospital, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

368

Objectives 67Ga-citrate has been used in the diagnostic of inflammatory-infectious diseases. Although accurate,67Ga-citrate scintigraphy presents some practical disadvantages.Ga68 is a positron emitting isotope for PET diagnostics with short half life, high-energy photons, high spatial resolution, low costs, low dosimetry and a short time procedure. To preliminary evaluate the accuracy of 68Ga-citrate PET/CT imaging in inflammatory-infectious diseases.

Methods This study was approved by our local Ethical Committee. 38 pts (mean age 50) were enrolled, for a total of 47 scans. 8 had a suspected discitis, 25 osteomyelitis, 3 IBD, 2 other diseases (1 FUO (fever of unknown origin) 1 myocardial sarcoidosis). 9pts underwent also a post therapy scan. Each pt underwent a 68Ga-citrate PET/CT(GE Discovery LS or STE). PET images were interpreted considering clinical data. Both visual and semi-quantitative (SUV max) assessment was performed. PET results were compared to WBC scintigraphy, MR and histopathology (when possible) within 2 weeks and clinical follow up.

Results The image quality was high for each pt. 17/47 scans were negative and 30/47 were positive with mean SUV max 4,4. Among the negative PET, 3pts had a discal degeneration, 10 were studied after an effective treatment, 1 had an eosinophilic granuloma, 1 a FUO and 1 a myocardial sarcoidosis (small lesions). Among the positive PET we found three false positive results represented by 2 bone lymphomas and an osteoblastoma, whose diagnosis was reached only after biopsy (MR was positive for OM as well). Overall, we found 27 TP, 15 TN, 3 FP and 2 FN scans, giving respectively: sensitivity 93%, specificity 83%, PPV 90%, NPV 88%, accuracy 89%.

Conclusions Although preliminary, these data confirm the possible 68Ga-citrate role for diagnosis of bone infections, especially in consideration of its very favourable characteristics. However, more studied are required, including a comparison population evaluated with the more standard FDG

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
68Ga-Citrate PET/CT in patents with inflammatory/infectious disease
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
68Ga-Citrate PET/CT in patents with inflammatory/infectious disease
Cristina Nanni, Vincenzo Allegri, Lorenzo Fantini, Valentina Ambrosini, Gian Carlo Montini, Paolo Castellucci, Anna Rizzello, Domenico Rubello, Cinzia Pettinato, Stefano Fanti
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 368;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
68Ga-Citrate PET/CT in patents with inflammatory/infectious disease
Cristina Nanni, Vincenzo Allegri, Lorenzo Fantini, Valentina Ambrosini, Gian Carlo Montini, Paolo Castellucci, Anna Rizzello, Domenico Rubello, Cinzia Pettinato, Stefano Fanti
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 368;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties: Infectious Disease/Hematology

  • FDG PET/CT is useful for the early evaluation of response to therapy in patients affected by diskitis
  • FDG-PET/CT for diagnosing infectious complications in neutropenic patients
  • Role of 18F-FDG PET/CT in evaluation of patients with pyrexia of unknown origin
Show more General Clinical Specialties: Infectious Disease/Hematology

Hematology/Infectious Disease

  • 18F-FDG uptake in uninfected prosthetic vascular grafts: Frequency, patterns, intensity, & changes over time
  • Red cell mass (RCM) determination is essential for proper diagnosis of early stage polycythemia vera (PV)
  • Clinical utility of 18F-fluoro-L-thymidine (FLT) PET to evaluate bone marrow distribution and proliferation in patients with haematopoietic dysfunction
Show more Hematology/Infectious Disease

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire